Krystal Biotech, Inc. ($KRYS)
Filing Information
| Accession Number | 0001711279-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
38,250
Total Value
$4,196,080.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Common Stock | โ | Feb 9, 2026 | Exercise/Conversion | 12,500 | $63.55 | $794,375.00 | 31,818 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 9, 2026 | Sale | 2,000 | $270.56 | $541,115.80 | 29,818 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 9, 2026 | Sale | 5,700 | $271.66 | $1,548,477.39 | 24,118 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 9, 2026 | Sale | 2,824 | $272.51 | $769,562.31 | 21,294 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 9, 2026 | Sale | 928 | $273.71 | $254,000.56 | 20,366 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 9, 2026 | Sale | 552 | $274.64 | $151,600.62 | 19,814 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 9, 2026 | Sale | 400 | $275.68 | $110,272.00 | 19,414 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 9, 2026 | Sale | 96 | $277.88 | $26,676.48 | 19,318 | Direct | โ | View Details | |
Chief Accounting Officer | Common Stock | โ | Feb 9, 2026 | Gift | 750 | $0.00 | $0.00 | 18,568 | Direct | โ | View Details | |
Chief Accounting Officer | Stock Option (Right to Buy) | Derivative | Feb 9, 2026 | Exercise/Conversion | 12,500 | $0.00 | $0.00 | 12,500 | Direct | โ | View Details |